MENU 
EQA Catalogue Groups
(Click on a colour/icon to filter calendar entries)
Clinical Genetics and Genetic Counselling
Genomic and Inherited Disorders
Haematological Neoplasms
Individual Competency Assessment
Molecular Newborn Screening
Molecular Pathology
Multidisciplinary team (MDT) working
Pharmacogenomics
Preimplantation Genetic Testing (PGT)
Reproductive Genomics
Sample Handling
Technical (NGS and OGM)
Variant Classification and Nomenclature
Viral Sequencing
Other Events
GenQA EQA Enrolment Event
GenQA EQA Distribution Event
GenQA webinar
Conference
GenQA workshop
GenQA Participant meeting
GenQA office closed
Other
| «prev April 2025 next»
| ||||||
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
| Sun 30 | Mon 31 | Tue 1
Distribution 1 OPEN
2025 Colorectal cancer - core - OPENS Testing Period: 6 weeks
2025 Colorectal cancer - MMR (MSI) - OPENS Testing Period: 6 weeks
2025 Lung cancer - comprehensive (molecular) - OPENS Testing Period: 6 weeks
2025 Lung cancer - EGFR only - OPENS Testing Period: 6 weeks
2025 Melanoma - OPENS Testing Period: 6 weeks
2025 Microsatellite instability testing (MSI) - OPENS Testing Period: 6 weeks
2025 Cystic Fibrosis (CF) Molecular Newborn screening (bloodspots) - OPENS Testing Period: 4 weeks
2025 MCADD Molecular Newborn Screening (bloodspots) - OPENS Testing Period: 4 weeks
2025 SCID Molecular Newborn Screening (bloodspots) - OPENS Testing Period: 4 weeks
2025 Spinal Muscular Atrophy (SMA) Molecular Newborn screening (bloodspots) - OPENS Testing Period: 4 weeks | Wed 2 GenQA is pleased to host a webinar on the Generation Study, sequencing 100,000 newborn genomes to improve diagnosis of genetic conditions, with speakers Professor Emma Baple and Amanda Pichini. | Thu 3 | Fri 4 | Sat 5 |
| Sun 6 | Mon 7
Distribution 2 OPEN
2025 Chromosome instability syndromes - OPENS Testing Period: 8 weeks
2025 Developmental Delay - OPENS Testing Period: 8 weeks
2025 Differences in Sex Development (DSD) - OPENS Testing Period: 8 weeks
2025 Hypotonic Infant - OPENS Testing Period: 8 weeks
2025 Imprinting disorders - OPENS Testing Period: 8 weeks
2025 Infertility - OPENS Testing Period: 8 weeks
2025 Maternal cell contamination (MCC) & fetal sexing - OPENS Testing Period: 6 weeks | Tue 8 | Wed 9 | Thu 10 | Fri 11 | Sat 12 |
| Sun 13 | Mon 14
Distribution 3 OPEN
2025 Eye disorders - OPENS Testing Period: 18 weeks
2025 Familial endocrine tumour predisposition disorders - OPENS Testing Period: 7 weeks
2025 Familial Hypercholesterolaemia (FH) - OPENS Testing Period: 12 weeks
2025 Neurofibromatosis and rasopathies - OPENS Testing Period: 18 weeks
2025 Parathyroid and Calcium Regulation disorders - OPENS Testing Period: 7 weeks | Tue 15 | Wed 16 | Thu 17 | Fri 18
GenQA office closed: Good Friday
| Sat 19 |
| Sun 20 | Mon 21
GenQA office closed: Easter Monday
| Tue 22 | Wed 23 | Thu 24 | Fri 25 | Sat 26 |
| Sun 27 | Mon 28
Distribution 4 OPEN
2025 Ataxia & Hereditary Spastic Paraplegia (HSP) - OPENS Testing Period: 18 weeks
2025 Cardiac disorders - OPENS Testing Period: 18 weeks
2025 Charcot Marie Tooth disease (CMT) and related sensory and motor neuropathies - OPENS Testing Period: 7 weeks
2025 Epilepsy disorders - OPENS Testing Period: 18 weeks
2025 Familial colorectal cancer and polyposis - OPENS Testing Period: 18 weeks
2025 Gastroenterology and hepatology disorders - OPENS Testing Period: 18 weeks
2025 Hereditary Breast and Ovarian Cancer (HBOC) disorders - OPENS Testing Period: 18 weeks
2025 Inborn Errors of Metabolism (IEM) - OPENS Testing Period: 18 weeks
2025 Mitochondrial disease - OPENS Testing Period: 18 weeks
2025 Muscular dystrophies - OPENS Testing Period: 18 weeks
2025 Neurodegenerative disorders - OPENS Testing Period: 18 weeks
2025 Primary Immunodeficiency disorders (PID) - OPENS Testing Period: 18 weeks
2025 Renal disorders - OPENS Testing Period: 18 weeks
2025 Respiratory disorders - OPENS Testing Period: 18 weeks
2025 Skeletal dysplasia (including Osteogenesis Imperfecta) - OPENS Testing Period: 18 weeks
2025 Variant Validation - OPENS Testing Period: 18 weeks
2025 DNA quantification - OPENS Testing Period: 3 weeks | Tue 29 | Wed 30 | Thu 1 | Fri 2
2025 Cystic Fibrosis (CF) Molecular Newborn screening (bloodspots) - CLOSES
2025 MCADD Molecular Newborn Screening (bloodspots) - CLOSES
2025 SCID Molecular Newborn Screening (bloodspots) - CLOSES
2025 Spinal Muscular Atrophy (SMA) Molecular Newborn screening (bloodspots) - CLOSES | Sat 3 |
7872
NEWSLETTER SIGN UP